Adicet Bio Inc.

12.23-0.0100-0.08%Vol 19.68K1Y Perf 47.09%
Apr 19th, 2021 11:35 DELAYED
BID12.19 ASK12.27
Open12.39 Previous Close12.24
Pre-Market- After-Market-
 - -%  - -
Target Price
26.25 
Analyst Rating
— — 0.00
Potential %
113.94 
Finscreener Ranking
+ —    -
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
+ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap388.67M 
Earnings Rating
Buy
Price Range Ratio 52W %
32.02 
Earnings Date
6th May 2021

Today's Price Range

12.1512.60

52W Range

7.7721.70

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-7.20%
1 Month
-19.42%
3 Months
-6.56%
6 Months
-9.47%
1 Year
47.09%
3 Years
66.08%
5 Years
-47.80%
10 Years
70.75%

TickerPriceChg.Chg.%
ACET12.23-0.0100-0.08
AAPL134.500.34000.25
GOOG2 298.360.60000.03
MSFT259.31-1.4300-0.55
XOM56.40-0.2600-0.46
WFC44.170.33000.75
JNJ162.640.40000.25
FB303.14-3.0400-0.99
GE13.33-0.0600-0.45
JPM153.28-0.0200-0.01
Earnings HistoryEstimateReportedSurprise %
Q04 2020--0.46-
Q03 2020-0.74-2.84-283.78
Q02 2020-1.54-1.0531.82
Q01 2020-2.73-1.3351.28
Q04 2019-3.57-5.53-54.90
Q03 2019-3.78-4.76-25.93
Q02 2019-2.87-3.57-24.39
Q01 2019-0.36-0.38-5.56
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.4748.91Positive
6/2021 QR-0.4941.67Positive
12/2021 FY-2.0239.70Positive
12/2022 FY-2.4025.47Positive
Next Report Date6th May 2021
Estimated EPS Next Report-0.47
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume19.68K
Shares Outstanding31.78M
Trades Count294
Dollar Volume1.49M
Avg. Volume143.55K
Avg. Weekly Volume98.56K
Avg. Monthly Volume114.59K
Avg. Quarterly Volume161.28K

Adicet Bio Inc. (NASDAQ: ACET) stock closed at 12.24 per share at the end of the most recent trading day (a -5.48% change compared to the prior day closing price) with a volume of 56.60K shares and market capitalization of 388.67M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 0 people. Adicet Bio Inc. CEO is Chen Schor.

The one-year performance of Adicet Bio Inc. stock is 47.09%, while year-to-date (YTD) performance is -12.88%. ACET stock has a five-year performance of -47.8%. Its 52-week range is between 7.77 and 21.7, which gives ACET stock a 52-week price range ratio of 32.02%

Adicet Bio Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 1.22, a price-to-sale (PS) ratio of 14.43, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -30.23%, a ROC of -19.36% and a ROE of -166.32%. The company’s profit margin is -%, its EBITDA margin is -77.60%, and its revenue ttm is $17.90 Million , which makes it $0.91 revenue per share.

Of the last four earnings reports from Adicet Bio Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.47 for the next earnings report. Adicet Bio Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Adicet Bio Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Adicet Bio Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Adicet Bio Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of 123.00%.

Adicet Bio Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 12.76, ATR14 : 1.19, CCI20 : -120.65, Chaikin Money Flow : -0.15, MACD : -0.51, Money Flow Index : 57.04, ROC : -5.99, RSI : 42.31, STOCH (14,3) : 22.84, STOCH RSI : 0.00, UO : 37.00, Williams %R : -77.16), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Adicet Bio Inc. in the last 12-months were: Chen Schor (Sold 49 398 shares of value $678 898 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Summary Rating---

Adicet Bio Inc.

Adicet Bio Inc is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.

CEO: Chen Schor

Telephone: +1 857 315-5528

Address: 200 Construction Drive, Menlo Park 94025, CA, US

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

75%25%

Bearish Bullish

58%42%

Bearish Bullish

53%47%

Bearish Bullish

70%30%

News

Stocktwits